Anouk C. De Jong

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancer.

Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancer.

Journal: Molecular oncology

Published: July 25, 2024

Quality of science journalism in the age of Artificial Intelligence explored with a mixed methodology.

Quality of science journalism in the age of Artificial Intelligence explored with a mixed methodology.

Journal: PloS one

Published: January 18, 2024

Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate Cancer.

Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate Cancer.

Journal: JCO precision oncology

Published: December 07, 2023

68Ga-PSMA PET/CT for Response Evaluation of 223Ra Treatment in Metastatic Prostate Cancer.

68Ga-PSMA PET/CT for Response Evaluation of 223Ra Treatment in Metastatic Prostate Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: January 19, 2023

Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning.

Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning.

Journal: Nature communications

Published: September 09, 2022

Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients.

Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients.

Journal: Cancers

Published: July 30, 2022

Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump Inhibitors.

Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump Inhibitors.

Journal: Clinical pharmacology in drug development

Published: March 29, 2022

Comparison of 68Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Primary Staging of Prostate Cancer: A Systematic Review and Meta-analysis.

Comparison of 68Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Primary Staging of Prostate Cancer: A Systematic Review and Meta-analysis.

Journal: European urology open science

Published: August 05, 2021

Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.

Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 21, 2020

Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients.

Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients.

Journal: Genome medicine

Published: March 27, 2020

68Ga-PSMA-Guided Bone Biopsies for Molecular Diagnostics in Patients with Metastatic Prostate Cancer.

68Ga-PSMA-Guided Bone Biopsies for Molecular Diagnostics in Patients with Metastatic Prostate Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 27, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026